No Data
Spero Therapeutics (SPRO.US) will release its earnings report after the market closes on May 13.
$Spero Therapeutics(SPRO.US)$ is scheduled to release its earnings report after the market closes on May 13. Investors are advised to stay tuned. What were the previous results? $Spero Therapeutics(SPRO.US)$ reported revenue of $41.297 million, net profit of $31.520 million, and earnings per share of $0.53 in Q4 2025. In Q1 2025, the company reported revenue of $5.874 million, a net loss of $13.866 million, and earnings per share of -$0.25. The above data was prepared in accordance with US accounting standards.
Express News | Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Press Release: Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
Express News | Spero Therapeutics Inc - Cash as of Dec 31, 2025 Sufficient to Fund Operations Into 2028
Spero Therapeutics | 8-K: Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Spero Therapeutics Q4 EPS $0.53 Beats $(0.40) Estimate, Sales $41.297M Up From $15.044M YoY